Quality Standards Resource Centre

This resource informs older Australians about their rights and choices regarding medication, including potential side effects, the importance of informed decision-making, and reducing unnecessary antibiotic and psychotropic use. It offers brochures, videos, and fact sheets to support understanding and provide guidance on alternative treatments and safe medication practices. 

This resource may refer to information that will be updated from 1 November 2025 to align with the new Aged Care Act and Quality Standards. 

This resource provides information on medication management in aged care, focusing on psychotropics and antimicrobials. It includes tools for reducing inappropriate use, antimicrobial stewardship guidance, self-assessment resources, and quality bulletins. It aims to improve medication safety, prevent inappropriate prescribing, and support care providers in ensuring safe clinical practices.

This resource may refer to information that will be updated from 1 November 2025 to align with the new Aged Care Act and Quality Standards. 

This resource outlines essential principles to support safe and high-quality transitions of care for people across healthcare settings, including aged care. It emphasises person-centred approaches, multidisciplinary collaboration, secure record systems, and continuity of care, aiming to minimise risks during care transitions for vulnerable populations. 

This resource may refer to information that will be updated from 1 November 2025 to align with the new Aged Care Act and Quality Standards.

This resource outlines the principles of safe and high-quality transitions of care. It highlights the importance of person-centred care, multidisciplinary collaboration, and clear communication between providers. It ensures coordination, accountability, and secure documentation to support continuity of care when transferring people between care settings. This resource may refer to information that will be updated from 1 November 2025 to align with the new Aged Care Act and Quality Standards.

This is a presentation on Polypharmacy Consumer Perspective. It includes details of a case example, resolution and care management, and key principles related to medicines and goal of care. This resource may refer to information that will be updated from 1 November 2025 to align with the new Aged Care Act and Quality Standards.

This resource outlines the Pharmaceutical Benefits Scheme (PBS) medication chart's maximum duration in residential aged care. It explains the use of both paper-based and electronic National Residential Medication Charts (NRMC), highlighting their role in managing prescriptions, medication supply, and administration. The document provides guidance on compliance, chart expiry, and medication safety within aged care facilities. This resource may refer to information that will be updated from 1 November 2025 to align with the new Aged Care Act and Quality Standards.

This resource is a fictional scenario that follows an older person’s care pathway with a residential aged care provider. The resource focuses on the systems and processes to support high-quality care of older people living with cognitive impairment. It includes 4 key priority areas: person-centred care, medication management, managing changed behaviours and transitions of care. 

This resource may refer to information that will be updated from 1 November 2025 to align with the new Aged Care Act and Quality Standards.

This resource is a fictional scenario that follows an older person’s care pathway with an in-home aged care provider. The resource focuses on the systems and processes to support high-quality care of older people living with dementia. It includes 4 key priority areas: person-centred care, medication management, managing changed behaviours and transitions of care. 

This resource may refer to information that will be updated from 1 November 2025 to align with the new Aged Care Act and Quality Standards.

This fact sheet is informed by the Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard (CCS), developed by the Australian Commission on Safety and Quality in Health Care. The CCS describes the safe and appropriate use of psychotropic medicines for people with cognitive disability or impairment, in a way that upholds their rights, dignity, health and quality of life. 

This resource may refer to information that will be updated from 1 November 2025 to align with the new Aged Care Act and Quality Standards.

This resource outlines clinical governance and quality improvement systems to support safe medication management. It requires health service organisations to implement systems for procuring, prescribing, dispensing, and monitoring medicines. 

This resource may refer to information that will be updated from 1 November 2025 to align with the new Aged Care Act and Quality Standards.

This page offers a wide range of resources aimed at helping aged care providers deliver culturally inclusive services. It includes multilingual communication cards, cultural care plans, and practice guides that help address the cultural, linguistic, and spiritual needs of people in care. The resources make sure aged care services are accessible, safe, and appropriate for culturally and linguistically diverse populations​.

This resource presents the Draft National Consumer Engagement Strategy for Health and Wellbeing, which aims to foster partnerships between health policymakers and communities. It is designed to involve people and communities in the development and implementation of preventive health policies. The strategy supports policymakers and program developers in engaging effectively with consumers to achieve improved health outcomes across Australia. 

This resource provides a guide for engaging consumers and carers in mental health services. It outlines steps for involving people in decision-making, service design, and evaluation. The guide emphasises co-design, leadership, and dedicated resources to create a person-centred approach that improves care and service outcomes.

This resource outlines the framework for electronic prescribing, offering an alternative to paper prescriptions for healthcare providers and consumers. It explains the benefits of electronic prescriptions, such as reducing errors, improving efficiency, and supporting medication safety. The resource also covers technical and legislative requirements for implementing electronic prescriptions in various healthcare settings. 

This resource may refer to information that will be updated from 1 November 2025 to align with the new Aged Care Act and Quality Standards.

This resource provides an overview of electronic prescriptions, which offer a digital alternative to paper prescriptions. It explains how electronic prescriptions can be issued by healthcare providers and stored on digital devices for convenience. The resource also details the benefits of the Active Script List (ASL) for managing multiple prescriptions, enhancing efficiency and medicine safety.

This resource describes the professional obligations of pharmacists when supporting Aboriginal and Torres Strait Islander peoples with culturally safe and responsive care and medicines management. It includes information about appropriate and effective processes, desired behaviour or minimum standards of good practice and information about duties and responsibilities. 

This resource may refer to information that will be updated from 1 November 2025 to align with the new Aged Care Act and Quality Standards.

This page provides information on the intent of the Residential Medication Management Review and Quality Use of Medicines (RMMR) Program. It outlines its purpose, participation requirements, claiming and payment processes, frequently asked questions, program rules, and extra available downloads.

This resource is chapter six of the Fourth Atlas 2021 of Healthcare Variations. The chapter examines medicines use in people aged 75 and over, focusing on polypharmacy, medication management reviews (MMRs), and proton pump inhibitor (PPI) dispensing. It highlights variations in medication use and recommends improving access to MMR services and interventions for safe, effective medication use in older populations. 

The Poisons Standard (SUSMP) is a resource that classifies medicines and chemicals into schedules for regulatory control in Australia. It outlines guidelines for labelling, packaging, and handling of substances. Key points include updates on scheduling decisions, which assist in public safety, healthcare, and chemical management. 

This resource may refer to information that will be updated from 1 November 2025 to align with the new Aged Care Act and Quality Standards.

This resource provides guidance on high-risk medicines, including safety alerts, notices, and best practices for safe prescribing, dispensing, and administration. It includes information on insulin and anticoagulant safety, monitoring tools, and best practice recommendations to improve medication safety and reduce harm from high-risk medications across healthcare settings. 

This resource may refer to information that will be updated from 1 November 2025 to align with the new Aged Care Act and Quality Standards.